Real‐time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologies
Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Florinda Gilsanz(Hospital Universitario HM Madrid), Silvia Grande(Research Institute Hospital 12 de Octubre), Almudena Crooke(Universidad Complutense de Madrid), J.C. Meneu, Antonio Jiménez‐Velasco(Hospital Doctor José Molina Orosa), Rosa Ayala(Hospital Universitario 12 De Octubre), Soledad Gamarra(Research Institute Hospital 12 de Octubre)
Cited by 9
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523